AC
Armistice Capital Portfolio holdings
AUM
$2.64B
1-Year Return
0.99%
This Quarter Return
-2.75%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$3.82B
AUM Growth
+$67.2M
(+1.8%)
Cap. Flow
+$299M
Cap. Flow
% of AUM
7.83%
Top 10 Holdings %
Top 10 Hldgs %
29.38%
Holding
407
New
72
Increased
86
Reduced
65
Closed
155
Top Buys
| 1 |
Alkermes
ALKS
|
$48.8M |
| 2 |
Supernus Pharmaceuticals
SUPN
|
$45.5M |
| 3 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
$37.9M |
| 4 |
Simply Good Foods
SMPL
|
$34.6M |
| 5 |
Immunovant
IMVT
|
$32.5M |
Top Sells
| 1 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
$92.8M |
| 2 |
Agios Pharmaceuticals
AGIO
|
$38.2M |
| 3 |
Coca-Cola
KO
|
$37M |
| 4 |
argenx
ARGX
|
$27.5M |
| 5 |
Post Holdings
POST
|
$26.8M |
Sector Composition
| 1 | Healthcare | 68.75% |
| 2 | Consumer Staples | 10.83% |
| 3 | Consumer Discretionary | 10.27% |
| 4 | Technology | 7.69% |
| 5 | Materials | 0.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AIM
151
AIM ImmunoTech Inc.
AIM
$6.72M
| $1.52M | 0.02% |
+40,780
| New | +$1.52M |
|
|
DPRO
152
Draganfly
DPRO
$81.5M
| $1.51M | 0.02% |
+258,920
| New | +$1.51M |
|
|
CANF
153
Can-Fite BioPharma
CANF
$10.3M
| $1.34M | 0.02% |
518,853
+136,055
| +36% | +$351K |
|
|
APTO
154
DELISTED
Aptose Biosciences, Inc.
APTO
| $1.3M | 0.02% |
+57,100
| New | +$1.3M |
|
155
Bionano Genomics
BNGO
$18.7M
| $1.14M | 0.01% |
+27,967
| New | +$1.14M |
|
|
EVAX
156
Evaxion A/S American Depositary Share
EVAX
$18.4M
| $1.14M | 0.01% |
78,400
+5,000
| +7% | +$72.5K |
|
157
Protara Therapeutics
TARA
$122M
| $1.08M | 0.01% |
+520,000
| New | +$1.08M |
|
158
VistaGen Therapeutics
VTGN
$109M
| $1.04M | 0.01% |
300,000
-64,000
| -18% | -$223K |
|
159
Nektar Therapeutics
NKTR
$764M
| $1.04M | 0.01% |
+55,733
| New | +$1.04M |
|
160
DexCom
DXCM
$31.6B
| $944K | 0.01% |
+8,328
| New | +$944K |
|
|
NEUP
161
Neuphoria Therapeutics Inc. Common Stock
NEUP
$22.4M
| $941K | 0.01% |
+102,230
| New | +$941K |
|
162
Accuray
ARAY
$170M
| $910K | 0.01% |
+500,000
| New | +$910K |
|
163
AYTU BioPharma
AYTU
$20.2M
| $736K | 0.01% |
+252,000
| New | +$736K |
|
164
Inhibikase Therapeutics
IKT
$124M
| $713K | 0.01% |
+589,575
| New | +$713K |
|
|
VIVS
165
VivoSim Labs, Inc. Common Stock
VIVS
$6.53M
| $708K | 0.01% |
+77,417
| New | +$708K |
|
|
AWH
166
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $697K | 0.01% |
468,000
-689,000
| -60% | -$1.03M |
|
167
Castellum
CTM
$100M
| $660K | 0.01% |
3,547,987
-1,108,000
| -24% | -$206K |
|
168
SPDR S&P Retail ETF
XRT
$441M
| $658K | 0.01% |
+8,782
| New | +$658K |
|
169
Clorox
CLX
$15.5B
| $619K | 0.01% |
+4,538
| New | +$619K |
|
|
VCNX
170
DELISTED
Vaccinex, Inc. Common Stock
VCNX
| $610K | 0.01% |
94,000
-51,000
| -35% | -$331K |
|
|
PPBT
171
Purple Biotech
PPBT
$1.75M
| $553K | 0.01% |
67,900
-37,850
| -36% | -$308K |
|
172
Moleculin Biotech
MBRX
$11.3M
| $549K | 0.01% |
156,000
+7,505
| +5% | +$26.4K |
|
|
HEPA
173
DELISTED
Hepion Pharmaceuticals
HEPA
| $526K | 0.01% |
10,320
+2,520
| +32% | +$129K |
|
174
NLS Pharmaceutics
NLSP
$9.62M
| $501K | 0.01% |
57,775
+3,475
| +6% | +$30.1K |
|
175
On Holding
ONON
$14.9B
| $497K | 0.01% |
12,811
-146,898
| -92% | -$5.7M |
|